ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns

July 27, 1990

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

In Brief: Einstein Center Wins BMS Research Grant; M.D. Anderson Honors Frederick Becker

March 26, 1999

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011